LKL International Stock price

Equities

LKL

MYQ0182OO004

Medical Equipment, Supplies & Distribution

End-of-day quote BURSA MALAYSIA 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
0.115 MYR -4.17% Intraday chart for LKL International -4.17% -20.69%
Sales 2021 53.3M 11.26M Sales 2022 81.98M 17.33M Capitalization 36.92M 7.8M
Net income 2021 -36M -7.61M Net income 2022 -16M -3.38M EV / Sales 2021 -0.36 x
Net cash position 2021 73.78M 15.59M Net cash position 2022 16.72M 3.53M EV / Sales 2022 0.25 x
P/E ratio 2021
-0.95 x
P/E ratio 2022
-2.15 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 54.78%
More Fundamentals * Assessed data
Dynamic Chart
LKL International Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
LKL International Berhad Announces Termination of Memorandum of Understanding with Serv Medical Pte. Ltd CI
LKL International Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
LKL International Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
LKL International, MediTop Sign Medical Device Distribution Deal MT
LKL International Berhad Appoints Haji Mohd Yazid Bin Haji Mustafa as Independent and Non Executive Chairman CI
LKL International Berhad Announces Appointment of Tan Su Ning as Independent and Non Executive Director CI
LKL International Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
LKL International Berhad Appoints Winnie Goh Kah Mun as Joint Secretary CI
LKL International to Sell Serv Medical's Products in Malaysia MT
LKL International Berhad Enters into Memorandum of Understanding with Serv Medical Pte Ltd CI
LKL International Berhad Reports Earnings Results for the Fifteen Months Ended December 31, 2022 CI
LKL International Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
LKL International Berhad Announces Resignation of Miss Sia Su Lin as Chief Financial Officer CI
LKL International Berhad Reports Earnings Results for the Third Quarter Ended September 30, 2022 CI
More news
1 day-4.17%
1 week-4.17%
1 month-4.17%
3 months-28.12%
6 months-23.33%
Current year-20.69%
More quotes
1 week
0.11
Extreme 0.11
0.12
1 month
0.11
Extreme 0.11
0.13
Current year
0.11
Extreme 0.11
0.16
1 year
0.11
Extreme 0.11
0.23
3 years
0.11
Extreme 0.11
4.65
5 years
0.11
Extreme 0.11
20.20
10 years
0.11
Extreme 0.11
20.20
More quotes
Managers TitleAgeSince
Director of Finance/CFO 52 21-08-15
Chief Tech/Sci/R&D Officer 38 15-06-30
Chief Administrative Officer 43 -
Members of the board TitleAgeSince
Director/Board Member 44 21-04-11
Director/Board Member 51 21-03-28
Director/Board Member 45 20-10-13
More insiders
Date Price Change Volume
24-03-27 0.115 -4.17% 1,775,700
24-03-26 0.12 +4.35% 4,638,200
24-03-25 0.115 -4.17% 1,222,300
24-03-22 0.12 +4.35% 1,100,400
24-03-21 0.115 -4.17% 1,994,800

End-of-day quote BURSA MALAYSIA, March 26, 2024

More quotes
LKL International Berhad is an investment holding company. The Company is engaged in manufacturing a suite of medical and healthcare products, comprising medical/ healthcare beds, medical peripherals, and related accessories under the LKL brand. The Company operates through four segments: Manufacturing division, Trading division, Investment holding division, and Retail division. The Manufacturing division is involved in manufacturing of medical/healthcare beds, medical peripherals, and accessories. The Trading division is involved in trading of medical furniture, medical devices, medical peripherals, and accessories. Its Investment holding division is engaged in investment holding activities. The Retail division is involved in retail business of pharmacy. The Company's subsidiaries include LKL Advance Metaltech Sdn. Bhd., Medik Gen Sdn.Bhd., Aluxcare Wellness Sdn. Bhd., Carelife Center Sdn. Bhd., LKL Medical (Sarawak) Sdn. Bhd. and TMI Medik Group Sdn. Bhd.
More about the company
  1. Stock
  2. Equities
  3. Stock LKL International - BURSA MALAYSIA